United Therapeutics Announces First Patient Enrolled in Phase 3 TETON PPF Study of Nebulized Tyvaso in Patients with Progressive Pulmonary Fibrosis

Up to 60,000 patients in the United States may have PPF, with only one approved therapy available

...

Related Keywords

Virginia ,United States ,Inova Fairfax Hospital ,Natalie Breytenbach ,Steven Nathan ,United Therapeutics Corporation Nasdaq ,Global Product Development At United Therapeutics ,United Therapeutics Corporation ,Drug Administration ,Exchange Commission ,Inhalation Solution ,Medical Director ,Advanced Lung Disease ,Lung Transplant Program ,Falls Church ,Associate Director ,Global Product Development ,United Therapeutics ,Inhalation Powder ,Brief Interstitial Lung Disease ,Arterial Hypertension ,Private Securities Litigation Reform Act ,Annual Report ,Quarterly Reports ,Current Reports ,Markets ,